Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

Nanoparticle-Mediated Interleukin-12 Cancer Gene Therapy

(2016) Crispin Dass et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients

(2013) Katarzyna Pogoda et al.   MEDICAL ONCOLOGY

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

(2013) M. Gil et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice

(2012) D. Chinnasamy et al.   CLINICAL CANCER RESEARCH

Re: Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

(2012) A. C. Wolff et al.   JNCI-Journal of the National Cancer Institute

Cancer Immunotherapy Using a Membrane-bound Interleukin-12 With B7-1 Transmembrane and Cytoplasmic Domains

(2012) Wen-Yu Pan et al.   MOLECULAR THERAPY

Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer

(2012) Michael G. Hanna et al.   Human Vaccines & Immunotherapeutics

ELISpot for measuring human immune responses to vaccines

(2011) Meredith Slota et al.   Expert Review of Vaccines

Tumor-Resident CD8+ T-cell: The Critical Catalyst in IL-12-Mediated Reversal of Tumor Immune Suppression

(2010) Nejat K. Egilmez et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Cancer Electrogene Therapy with Interleukin-12

(2010) Maja Cemazar et al.   CURRENT GENE THERAPY

Therapeutic cancer vaccines: are we there yet?

(2010) Christopher A. Klebanoff et al.   IMMUNOLOGICAL REVIEWS

HER-2/neu as a target for cancer vaccines

(2010) Constantin N Baxevanis et al.   Immunotherapy

Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12

(2010) David A. Zaharoff et al.   JOURNAL OF IMMUNOTHERAPY

Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer

(2009) Michael S. Sabel et al.   BREAST CANCER RESEARCH AND TREATMENT

Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12

(2009) D. A. Zaharoff et al.   CANCER RESEARCH

IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments

(2009) Michelle R. Simpson-Abelson et al.   CLINICAL IMMUNOLOGY

Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer

(2009) K Anwer et al.   GENE THERAPY

Central Role of Tumor-Associated CD8+ T Effector/Memory Cells in Restoring Systemic Antitumor Immunity

(2009) M. O. Kilinc et al.   JOURNAL OF IMMUNOLOGY

Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity

(2009) M. C. Rodriguez-Galan et al.   JOURNAL OF IMMUNOLOGY

Activated CD8+ T-Effector/Memory Cells Eliminate CD4+ CD25+ Foxp3+ T-Suppressor Cells from Tumors via FasL Mediated Apoptosis

(2009) M. O. Kilinc et al.   JOURNAL OF IMMUNOLOGY

Twelve immunotherapy drugs that could cure cancers

(2008) Martin A. ‘Mac’ Cheever   IMMUNOLOGICAL REVIEWS

Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor

(2008) Adil I. Daud et al.   JOURNAL OF CLINICAL ONCOLOGY

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

(2008) A. M. Brewster et al.   JNCI-Journal of the National Cancer Institute